N. J. Lygidakis

Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem.

J. Parissis, N. Ziras, N. J. Lygidakis, 1995, Hepato-gastroenterology.

Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.

J. Parissis, P. Kosmidis, N. Lygidakis, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.

T. Konstantinidou, N. J. Lygidakis, J. Pothoulakis, 1994, Anticancer research.

Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.

A. Konstantinidou, N. J. Lygidakis, J. Pothoulakis, 1995, Anticancer research.

The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.

M. Makuuchi, F. Orsi, A. Goldhirsch, 2009, Critical reviews in oncology/hematology.

Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?.

N. J. Lygidakis, P. Papadopoulou, 1995, Hepato-Gastroenterology.

Transarterial locoregional immunostimulation and chemotherapy in patients with unresectable secondary liver tumours.

N. J. Lygidakis, A. Kapetanakis, G. Savanis, 1994, Anticancer research.